SCHEMBL30367657

SCHEMBL30367657

CC(C)(C)OC(=O)N1C[C@H]2CC(Nc3cc(C(C)(F)F)c(Cl)nn3)C[C@H]2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.41
USP30 Q70CQ3 1/20 0.38
GPR119 Q8TDV5 4/20 0.37
JAK1 P23458 1/20 0.37
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
POLB P06746 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LIPE Q05469 1/20 0.34
EHMT2 Q96KQ7 1/20 0.34
RORC P51449 1/20 0.34
CNR1 P21554 1/20 0.34
CDK9 P50750 1/20 0.34
SYK P43405 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30455542 0.94 NR1H2 (0.41) NR1H2USP30GPR119JAK1HDAC1
SCHEMBL25625907 0.94 NR1H2 (0.41) NR1H2USP30GPR119JAK1HDAC1
SCHEMBL23956997 0.94 NR1H2 (0.41) NR1H2USP30GPR119JAK1HDAC1
SCHEMBL30367419 0.92 NR1H2 (0.43) NR1H2USP30GPR119JAK1HDAC1
SCHEMBL29919449 0.86 NR1H2 (0.46) NR1H2USP30GPR119JAK1HDAC1
SCHEMBL24575390 0.86 NR1H2 (0.46) NR1H2USP30GPR119JAK1HDAC1
SCHEMBL29919177 0.85 NR1H2 (0.40) NR1H2USP30GPR119JAK1HDAC1
SCHEMBL24575034 0.85 NR1H2 (0.40) NR1H2USP30GPR119JAK1HDAC1
SCHEMBL24740784 0.84 USP30 (0.42) NR1H2USP30GPR119JAK1POLB
SCHEMBL30367416 0.84 NR1H2 (0.41) NR1H2USP30GPR119JAK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230122344-A1 ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 UNITED STATES GOVERNMENT 2023-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230122344-A1 ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 CHRM2, CHRM3, CHRM4 NR1H2 455/4885USP30 3134/4885GPR119 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.